Astrazeneca Plc

0A4J
0,00
0,00 (0,00%)
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/1/202416:00UKREGAstraZeneca PLC Total Voting Rights
27/12/202308:00UKREGAstraZeneca PLC AstraZeneca acquires Gracell
22/12/202308:00UKREGAstraZeneca PLC Wainua (eplontersen) granted first US FDA..
14/12/202316:00UKREGAstraZeneca PLC Director/PDMR Shareholding
12/12/202308:05UKREGAstraZeneca PLC AstraZeneca to acquire Icosavax
01/12/202316:05UKREGAstraZeneca PLC Block listing Interim Review
01/12/202316:00UKREGAstraZeneca PLC Total Voting Rights
01/12/202308:00UKREGAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence..
23/11/202316:00UKREGAstraZeneca PLC Director/PDMR Shareholding
17/11/202308:00UKREGAstraZeneca PLC Truqap approved in US for HR+ breast cancer
14/11/202308:05UKREGAstraZeneca PLC Update on PACIFIC-2 Phase III trial for..
09/11/202316:00UKREGAstraZeneca PLC Director Declaration
09/11/202308:10UKREGAstraZeneca PLC Imfinzi combination improves PFS in liver..
09/11/202308:05UKREGAstraZeneca PLC Agreement with Eccogene for clinical stage..
09/11/202308:00UKREGAstraZeneca PLC 9M and Q3 2023 results
01/11/202316:00UKREGAstraZeneca PLC Total Voting Rights
01/11/202308:00UKREGAstraZeneca PLC AstraZeneca cell & gene therapy deal w/..
03/10/202308:00UKREGAstraZeneca PLC AstraZeneca settles Nexium liability..
02/10/202316:00UKREGAstraZeneca PLC Total Voting Rights
22/9/202308:00UKREGAstraZeneca PLC Dato-DXd improved PFS in breast cancer
20/9/202308:00UKREGAstraZeneca PLC Alexion completes Pfizer gene therapy..
15/9/202316:00UKREGAstraZeneca PLC Enhertu recommended in EU for HER2-mutant..
11/9/202317:00UKREGAstraZeneca PLC Fasenra Phase III EGPA trial met primary..
06/9/202308:00UKREGAstraZeneca PLC Update on US review of Ultomiris for NMOSD
01/9/202316:00UKREGAstraZeneca PLC Total Voting Rights
01/8/202316:00UKREGAstraZeneca PLC Total Voting Rights
28/7/202308:05UKREGAstraZeneca PLC Alexion enters gene therapy agreement with..
28/7/202308:00UKREGAstraZeneca PLC Half-year Report
17/7/202319:10UKREGAstraZeneca PLC Beyfortus approved in US for infant RSV..
03/7/202316:00UKREGAstraZeneca PLC Total Voting Rights
03/7/202308:00UKREGAstraZeneca PLC Dato-DXd significantly improved PFS in lung..
09/6/202308:05UKREGAstraZeneca PLC nirsevimab recommended for infant RSV..
09/6/202308:00UKREGAstraZeneca PLC AstraZeneca agreement with Quell..
02/6/202318:00UKREGAstraZeneca PLC Imfinzi improved pCR in gastric and GEJ..
01/6/202316:05UKREGAstraZeneca PLC Block listing Interim Review
01/6/202316:00UKREGAstraZeneca PLC Total Voting Rights
01/6/202308:00UKREGAstraZeneca PLC Lynparza approved in US for BRCAm prostate..
26/5/202308:00UKREGAstraZeneca PLC Imfinzi + Lynparza prolonged PFS in..
22/5/202308:05UKREGAstraZeneca PLC Directorate Change
17/5/202308:00UKREGAstraZeneca PLC Tagrisso plus chemo improved PFS in lung..
09/5/202312:00UKREGAstraZeneca PLC Director/PDMR Shareholding
09/5/202308:00UKREGAstraZeneca PLC Farxiga extended in the US for heart failure
Apertura: Min: Max:
Chiusura:

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network